𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Excess HBcAg in HBc antibody–negative chronic hepatitis B virus carriers

✍ Scribed by Yamina Lazizi; Pascal Dubreuil; Professor Jacques Pillot

Publisher
John Wiley and Sons
Year
1993
Tongue
English
Weight
576 KB
Volume
17
Category
Article
ISSN
0270-9139

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatitis B virus C gene heterogeneity i
Hepatitis B virus C gene heterogeneity in a familial cluster of anti-HBc negative chronic carriers
✍ G. Fiordalisi; D. Primi; E. Tanzi; E. Magni; C. Incarbone; A. R. Zanetti; E. Car 📂 Article 📅 1994 🏛 John Wiley and Sons 🌐 English ⚖ 563 KB

## Abstract We studied a familial cluster of adult HBV chronic carriers characterized by serological markers of active viral replication, normal or slightly elevated ALT levels and, in four out of five cases, absence of anti‐HBc reactivity. The nucleotide sequence of the pre‐C/C region of HBV was a

Hepatitis A Infection in Chronic Carrier
Hepatitis A Infection in Chronic Carriers of Hepatitis B Virus
✍ Reinhart Zachoval; Michael Roggendorf; Friedrich Deinhardt 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 441 KB 👁 2 views

By routine screening for serologic markers of hepatitis A and B in patients with acute hepatitis, 30 chronic carriers of hepatitis B virus with serologic evidence of acute hepatitis A and two patients with simultaneous acute infection with hepatitis A virus and hepatitis B virus were detected. For

Significance of serum IgM anti-HBc in ch
Significance of serum IgM anti-HBc in chronic hepatitis B virus infection
✍ Hather. M. Smith; Johnson Y. N. Lau; Susan E. Davies; Helena M. Daniels; Graeme 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 459 KB 👁 2 views

## Abstract Because of widely differing reports on the significance of IgM anti‐HBc in chronic hepatitis B virus (HBV) infection, paired sera and liver biopsies from 49 patients with chronic HBV infection were analysed for serum IgM anti‐HBc, HBsAg titre, HBeAgianti‐HBe, HBV DNA, serum aspartate tr

Foscarnet therapy in chronic hepatitis B
Foscarnet therapy in chronic hepatitis B virus e antigen carriers
✍ V. G. Bain; H. M. Daniels; A. Chanas; G. J. M. Alexander; Dr. Roger Williams 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 343 KB 👁 2 views

Foscarnet (trisodium phosphonoformate) is a novel antiviral agent that inhibits viral-specific DNA polymerase. In the present study, eight males with chronic HBV carriage (HBeAg and HBV-DNA seropositivity >I2 months) showing chronic persistent hepatitis (CPH) or chronic active hepatitis (CAH) on liv

Serial passage of hepatitis delta virus
Serial passage of hepatitis delta virus in chronic hepatitis B virus carrier chimpanzees
✍ Antonio Ponzetto; Francesco Negro; Hans Popper; Ferruccio Bonino; Ronald Engle; 📂 Article 📅 1988 🏛 John Wiley and Sons 🌐 English ⚖ 898 KB

Five consecutive passages of hepatitis delta virus in hepatitis B virus carrier chimpanzees were performed in order to further characterize the infectious and pathogenic nature of this naturally occurring defective virus. Three animals received identical inocula at fourth passage in order to assess

Serum hepatitis B virus-DNA cutoff level
Serum hepatitis B virus-DNA cutoff levels in hepatitis B e antigen–negative chronic hepatitis B virus infection
✍ George V. Papatheodoridis; Emanuel K. Manesis; Spilios Manolakopoulos; Athanasio 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 52 KB 👁 2 views

Commitment of bone marrow cells to hepatic stellate cells in mouse. J Hepatol 2004;40:255-260. 6. Kisseleva T, Uchinami H, Feirt N, Quintana-Bustamante O, Segovia JC, Schwabe RF, et al. Bone marrow-derived fibrocytes participate in pathogenesis of liver fibrosis. J Hepatol 2006;45:429-438. 7. Magnes